Gossamer Bio, Inc.
Market Cap
$109.20M
P/E Ratio
-0.68
EPS
$-0.69
Dividend Yield
0.00%
52-Week Range
$0.33 — $3.87
Volume
6.23M
Avg Volume
14.52M
Beta
2.11
P/E (TTM)
-0.68
Forward P/E
—
PEG Ratio
0.06
P/S (TTM)
2.42
P/B (TTM)
-1.27
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
5.94%
ROA (TTM)
-0.75%
ROIC
—
Gross Margin
1.00%
Operating Margin
-3.65%
Net Margin
—
Debt/Equity
-2.46
Current Ratio
3.28
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.52%
EPS Growth (5Y)
+0.31%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
$-0.58
EPS Est (Next Year)
$-0.24
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.79
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
231.46M
Float
187.91M
Free Float %
81.19%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2019-02-08
Employees
144
CEO
Faheem Hasnain
Index Membership
—
Website
https://www.gossamerbio.com
Gossamer Bio, Inc. (GOSS) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $109.20M, a P/E ratio of -0.68, GOSS is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare GOSS against other stocks using dozens of fundamental and technical filters.
Gossamer Bio, Inc. (GOSS) has a trailing twelve-month (TTM) P/E ratio of -0.68. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Gossamer Bio, Inc. (GOSS) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Gossamer Bio, Inc. (GOSS) has a market capitalization of $109.20 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.